stx-100
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT00878761)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Integrin alpha-V/beta-6INHIBITOR
Integrin alpha-V/beta-6 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109623 ↗
Also known as
- bg00011
- stx-100
- stx-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03573505 | Phase 2 | Sep 21, 2018 | Biogen |
| NCT01371305 | Phase 2 | Jul 16, 2012 | Biogen |
| NCT00878761 | Phase 2 | Sep 1, 2010 | Stromedix |
Showing 3 of 3 trials
Page 1 / 1